“Efficacy of Daclatasvir Plus Peginterferon Alfa and Ribavirin for Patients With Chronic Hepatitis C Genotype 4 Infection”. Bangladesh Journal of Pharmacology, vol. 12, no. 1, Mar. 2017, pp. 12-22, https://doi.org/10.3329/bjp.v12i1.29940.